NasdaqCM - Nasdaq Real Time Price USD

SELLAS Life Sciences Group, Inc. (SLS)

1.5850
-0.0950
(-5.64%)
As of 2:47:57 PM EDT. Market Open.
All numbers in thousands
Download
Breakdown
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Assets
19,432
6,219
20,943
26,275
Total Liabilities Net Minority Interest
9,967
14,195
16,092
5,928
Total Equity Gross Minority Interest
9,465
-7,976
4,851
20,347
Total Capitalization
9,465
-7,976
4,851
20,347
Common Stock Equity
9,465
-7,976
4,851
20,347
Capital Lease Obligations
1,001
906
945
808
Net Tangible Assets
7,551
-9,890
2,937
18,433
Working Capital
6,817
-10,563
2,241
18,062
Invested Capital
9,465
-7,976
4,851
20,347
Tangible Book Value
7,551
-9,890
2,937
18,433
Total Debt
1,001
906
945
808
Share Issued
78,581.9790
32,132.8900
21,005.4050
15,895.6370
Ordinary Shares Number
78,581.9790
32,132.8900
21,005.4050
15,895.6370
12/31/2021 - 3/12/2008

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

VSTM Verastem, Inc.
7.12
+2.59%
 
CRDF Cardiff Oncology, Inc.
2.6810
+1.94%
 
ALT Altimmune, Inc.
5.60
-3.53%
 
CADL Candel Therapeutics, Inc.
4.8100
+1.05%
 
IOVA Iovance Biotherapeutics, Inc.
1.7100
-46.06%
 
ICU SeaStar Medical Holding Corporation
1.2600
+1.61%
 
GLSI Greenwich LifeSciences, Inc.
9.50
-1.66%
 
ITRM Iterum Therapeutics plc
1.0200
-2.86%
 
ABEO Abeona Therapeutics Inc.
5.28
-3.92%
 
CAPR Capricor Therapeutics, Inc.
6.49
-6.89%